{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:51:55Z","timestamp":1790394715654,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY013574"],"award-info":[{"award-number":["EY013574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["EB000415"],"award-info":[{"award-number":["EB000415"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK35124"],"award-info":[{"award-number":["DK35124"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK72517"],"award-info":[{"award-number":["DK72517"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008087","name":"Guthy-Jackson Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0462-4","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T13:08:39Z","timestamp":1501160919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G"],"prefix":"10.1186","volume":"5","author":[{"given":"Xiaoming","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"462_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/2051-5960-2-48","volume":"2","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Verkman AS (2014) Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun 2:48","journal-title":"Acta Neuropathol Commun"},{"key":"462_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617\u2013629","journal-title":"Ann Neurol"},{"key":"462_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s002620000120","volume":"49","author":"I Bergman","year":"2000","unstructured":"Bergman I, Basse PH, Barmada MA, Griffin JA, Cheung NK (2000) Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer Immunol Immunother 49:259\u2013266","journal-title":"Cancer Immunol Immunother"},{"key":"462_CR4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","volume":"126","author":"RA Brodsky","year":"2015","unstructured":"Brodsky RA (2015) Complement in hemolytic anemia. Blood 126:2459\u20132465","journal-title":"Blood"},{"key":"462_CR5","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","volume":"286","author":"JM Crane","year":"2011","unstructured":"Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS (2011) Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1\/M23 isoforms and orthogonal arrays. J Biol Chem 286:16516\u201316524","journal-title":"J Biol Chem"},{"key":"462_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/BF02918257","volume":"12","author":"A Davies","year":"1993","unstructured":"Davies A, Lachmann PJ (1993) Membrane defence against complement lysis: the structure and biological properties of CD59. Immunol Res 12:258\u2013275","journal-title":"Immunol Res"},{"key":"462_CR7","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2169\/internalmedicine.51.7898","volume":"51","author":"S Deguchi","year":"2012","unstructured":"Deguchi S, Deguchi K, Sato K, Yunoki T, Omote Y, Morimoto N, Kurata T, Ikeda M, Takahashi T, Aoki M, Abe K (2012) HyperCKemia related to the initial and recurrent attacks of neuromyelitis optica. Intern Med 51:2617\u20132620","journal-title":"Intern Med"},{"key":"462_CR8","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.108.9.2993","volume":"108","author":"A Frigeri","year":"1995","unstructured":"Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS (1995) Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci 108:2993\u20133002","journal-title":"J Cell Sci"},{"key":"462_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/B978-0-444-63432-0.00021-9","volume":"133","author":"SR Hinson","year":"2016","unstructured":"Hinson SR, Lennon VA, Pittock SJ (2016) Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders. Handb Clin Neurol 133:377\u2013403","journal-title":"Handb Clin Neurol"},{"key":"462_CR10","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V85.8.2228.bloodjournal8582228","volume":"85","author":"N Iwamoto","year":"1995","unstructured":"Iwamoto N, Kawaguchi T, Nagakura S, Hidaka M, Horikawa K, Kagimoto T, Takatsuki K, Nakakuma H (1995) Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. Blood 85:2228\u20132232","journal-title":"Blood"},{"key":"462_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149\u2013164","journal-title":"Clin Exp Immunol"},{"key":"462_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/B978-0-12-800100-4.00006-4","volume":"121","author":"M Levy","year":"2014","unstructured":"Levy M, Wildemann B, Jarius S, Orellano B, Sasidharan S, Weber MS, Stuve O (2014) Immunopathogenesis of neuromyelitis optica. Adv Immunol 121:213\u2013242","journal-title":"Adv Immunol"},{"key":"462_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1172\/JCI231","volume":"100","author":"T Ma","year":"1997","unstructured":"Ma T, Yang B, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS (1997) Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest 100:957\u2013962","journal-title":"J Clin Invest"},{"key":"462_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/mus.24298","volume":"50","author":"R Malik","year":"2014","unstructured":"Malik R, Lewis A, Cree BA, Ratelade J, Rossi A, Verkman AS, Bollen AW, Ralph JW (2014) Transient hyperckemia in the setting of neuromyelitis optica (NMO). Muscle Nerve 50:859\u2013862","journal-title":"Muscle Nerve"},{"key":"462_CR15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/jamaneurol.2013.3124","volume":"70","author":"M Matiello","year":"2013","unstructured":"Matiello M, Schaefer-Klein J, Sun D, Weinshenker BG (2013) Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica. JAMA Neurol 70:1118\u20131125","journal-title":"JAMA Neurol"},{"key":"462_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","volume":"121","author":"Y Nevo","year":"2013","unstructured":"Nevo Y, Ben-Zeev B, Tabib A, Straussberg R, Anikster Y, Shorer Z, Fattal-Valevski A, Ta-Shma A, Aharoni S, Rabie M, Zenvirt S, Goldshmidt H, Fellig Y, Shaag A, Mevorach D, Elpeleg O (2013) CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood 121:129\u2013135","journal-title":"Blood"},{"key":"462_CR17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","volume":"72","author":"S Nishiyama","year":"2009","unstructured":"Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y (2009) A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72:1960\u20131961","journal-title":"Neurology"},{"key":"462_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrn3468","volume":"14","author":"MC Papadopoulos","year":"2013","unstructured":"Papadopoulos MC, Verkman AS (2013) Aquaporin water channels in the nervous system. Nat Rev Neurosci 14:265\u2013277","journal-title":"Nat Rev Neurosci"},{"key":"462_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS (2014) Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol 10:493\u2013506","journal-title":"Nat Rev Neurol"},{"key":"462_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1742-2094-7-60","volume":"7","author":"BG Perez-Nievas","year":"2010","unstructured":"Perez-Nievas BG, Garcia-Bueno B, Madrigal JL, Leza JC (2010) Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in dark agouti rats: mechanisms implicated. J Neuroinflamm 7:60","journal-title":"J Neuroinflamm"},{"key":"462_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","volume":"62","author":"J Ratelade","year":"2014","unstructured":"Ratelade J, Verkman AS (2014) Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica. Mol Immunol 62:104\u2013113","journal-title":"Mol Immunol"},{"key":"462_CR22","doi-asserted-by":"publisher","first-page":"e27412","DOI":"10.1371\/journal.pone.0027412","volume":"6","author":"J Ratelade","year":"2011","unstructured":"Ratelade J, Bennett JL, Verkman AS (2011) Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS One 6:e27412","journal-title":"PLoS One"},{"key":"462_CR23","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/glia.22417","volume":"60","author":"A Rossi","year":"2010","unstructured":"Rossi A, Ratelade J, Papadopoulos MC, Bennett JL, Verkman AS (2010) Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1\/M23 isoform content, or supramolecular assembly. Glia 60:2027\u20132039","journal-title":"Glia"},{"key":"462_CR24","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1177\/1352458515571446","volume":"21","author":"S Saadoun","year":"2015","unstructured":"Saadoun S, Papadopoulos MC (2015) Role of membrane complement regulators in neuromyelitis optica. Mult Scler 21:1644\u20131654","journal-title":"Mult Scler"},{"key":"462_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2010.02.007","volume":"221","author":"H Saini","year":"2010","unstructured":"Saini H, Fernandez G, Kerr D, Levy M (2010) Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity. J Neuroimmunol 221:68\u201372","journal-title":"J Neuroimmunol"},{"key":"462_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imr.12475","volume":"274","author":"CQ Schmidt","year":"2016","unstructured":"Schmidt CQ, Lambris JD, Ricklin D (2016) Protection of host cells by complement regulators. Immunol Rev 274:152\u2013171","journal-title":"Immunol Rev"},{"key":"462_CR27","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181dd445b","volume":"74","author":"N Suzuki","year":"2010","unstructured":"Suzuki N, Takahashi T, Aoki M, Misu T, Konohana S, Okumura T, Takahashi H, Kameya S, Yamaki K, Kumagai T, Fujihara K, Itoyama Y (2010) Neuromyelitis optica preceded by hyperCKemia episode. Neurology 74:1543\u20131545","journal-title":"Neurology"},{"key":"462_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-017-1734-6","volume":"134","author":"L Tradtrantip","year":"2017","unstructured":"Tradtrantip L, Yao X, Su T, Smith AJ, Verkman AS (2017) Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica. Acta Neuropathol 134:35\u201344","journal-title":"Acta Neuropathol"},{"key":"462_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaut.2014.05.004","volume":"54","author":"A Vaknin-Dembinsky","year":"2014","unstructured":"Vaknin-Dembinsky A, Karussis D, Avichzer J, Abramsky O (2014) NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases. J Autoimmun 54:93\u201399","journal-title":"J Autoimmun"},{"key":"462_CR30","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1242\/jcs.110.22.2855","volume":"110","author":"JM Verbavatz","year":"1997","unstructured":"Verbavatz JM, Ma T, Gobin R, Verkman AS (1997) Absence of orthogonal arrays in kidney, brain and muscle from transgenic knockout mice lacking water channel aquaporin-4. J Cell Sci 110:2855\u20132860","journal-title":"J Cell Sci"},{"key":"462_CR31","doi-asserted-by":"publisher","first-page":"731569","DOI":"10.1155\/2010\/731569","volume":"2010","author":"Y Wakayama","year":"2010","unstructured":"Wakayama Y (2010) Aquaporin expression in normal and pathological skeletal muscles: a brief review with focus on AQP4. J Biomed Biotechnol 2010:731569","journal-title":"J Biomed Biotechnol"},{"key":"462_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40478-017-0417-9","volume":"5","author":"X Yao","year":"2017","unstructured":"Yao X, Verkman AS (2017) Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G. Acta Neuropathol Commun 5:15","journal-title":"Acta Neuropathol Commun"},{"key":"462_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang H, Verkman AS (2014) Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 53:67\u201377","journal-title":"J Autoimmun"},{"key":"462_CR34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729\u2013740","journal-title":"Nat Rev Immunol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-017-0462-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T15:01:58Z","timestamp":1659279718000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0462-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0462-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"assertion":[{"value":"22 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"57"}}